首页> 外国专利> Novel 1,2,5-trisubstd. 1,2-dihydro-indazol-3-ones with anti-asthmatic, anti-allergic, anti-inflammatory, immuno-modulating and neuro-protective effects, method for production and use as medicam ent

Novel 1,2,5-trisubstd. 1,2-dihydro-indazol-3-ones with anti-asthmatic, anti-allergic, anti-inflammatory, immuno-modulating and neuro-protective effects, method for production and use as medicam ent

机译:新型1,2,5-三取代。具有抗哮喘,抗过敏,抗炎,免疫调节和神经保护作用的1,2-二氢吲唑-3-酮,其制备方法和用作药物

摘要

The invention relates to 1,2,5-trisubstituted 1,2-dihydroindazol-3-ones of formula (I)whereinX is -SO2-, -SO-, -(CH2)p-, -(CH2)p-O-, -(CH2)p-(C=O)-, -(CH2)p-(C=O)-NH-, -(CH2)p-CHOH-, -CHOH-(CH2)p-, -(CH2)p-CH=CH-, -CH=CH-(CH2)p-,Y is -(C=O)-, -(C=O)-NH-, -(C=O)-NH-(CH2)p-, -C=O)-(CH2)p-, -(CH2)p-, -(CH2)p-O-, -(CH2)p-(C=O)-, -(CH2)p-(C=O)-NH-, -(CH2)p-(C=O)-NH-(CH2)p-, -(CH2)p-CHOH-, -CHOH-(CH2)p-, -(CH2)p-CH=CH-, -CH=CH-(CH2)p-,Z is -O-, -O-(CH2)p-, -NH-, -NH-(C=O)-, -NH-(C=O)-NH-, -NH-(C=O)-O-, -NH-CH2-(C=O)- and -NH-(C=O)-CH2-,P is a cardinal number from 1 to 4,R1, R2 and R3 can be the same or different and are:mono-, bi- or tricyclic saturated or mono- or polyunsaturated carbocycles having from 5 to 14 ring members; or mono-, bi- or tricyclic saturated or mono- or polyunsaturated heterocycles having from 5 to 15 ring members and from 1 to 6 heteroatoms,in which the carbocycles and the heterocycles can be mono- or polysubstituted by:C1-6-alkyl, -O-C1-6-alkyl, -O-C3-7-cycloalkyl, mono-, bi- or tricyclic saturated or mono- or polyunsaturated carbocycles having from 3 to 14 ring members, mono-, bi- or tricyclic saturated or mono- or polyunsaturated heterocycles having from 5 to 15 ring members and from 1 to 6 heteroatoms,R1 is also H, provided that when X is CH2, then R1 is not H,R3-Z is also NO2,and their pharmaceutically acceptable salts,but excluding compounds of formula (I) in whichif Z is -NH-(C=O)-, -NH-(C=O)-NH-, -NH-(C=O)-O-, -NH-(C=O)-CH2 and at the same time R1 is phenyl, monosubstituted or polysubstituted by -COOH, -COOC1-6-alkyl, -(CH2)p-COOH, -(CH2)p-COOC1-6-alkyl -CONHC1-6-alkyl, -CONHC6-14-aryl, -CONHSO2C1-6-alkyl, -CONHSO2C6-4-aryl, 1H-tetrazol-5-yl, then R2 is not phenyl, monosubstituted or polysubstituted by CN, halogen, C1-4-alkyl, C1-4-alkyloxy, CF3; andif R3-Z is NO2, then R1-X is not benzyl or 4-methoxybenzyl, and R2-Y is not benzyl or 2-picolyl at the same time; and to pharmaceutical treatment processes, and processes for making.
机译:本发明涉及式(I)的1,2,5-三取代的1,2-二氢吲唑-3-酮,其中X是-SO2-,-SO-,-(CH2)p-,-(CH2)pO-,- (CH2)p-(C = O)-,-(CH2)p-(C = O)-NH-,-(CH2)p-CHOH-,-CHOH-(CH2)p-,-(CH2)p -CH = CH-,-CH = CH-(CH2)p-,Y为-(C = O)-,-(C = O)-NH-,-(C = O)-NH-(CH2)p -,-C = O)-(CH2)p-,-(CH2)p-,-(CH2)pO-,-(CH2)p-(C = O)-,-(CH2)p-(C = O)-NH-,-(CH2)p-(C = O)-NH-(CH2)p-,-(CH2)p-CHOH-,-CHOH-(CH2)p-,-(CH2)p- CH = CH-,-CH = CH-(CH2)p-,Z是-O-,-O-(CH2)p-,-NH-,-NH-(C = O)-,-NH-(C = O)-NH-,-NH-(C = O)-O-,-NH-CH2-(C = O)-和-NH-(C = O)-CH2-,P是从1开始的基数至4,R 1,R 2和R 3可以相同或不同,并且是:具有5至14个环成员的单,双或三环饱和或单或多不饱和碳环;或具有5至15个环成员和1至6个杂原子的单,双或三环饱和或单或多不饱和杂环,其中碳环和杂环可以被C 1-6烷基单取代或多取代, -O-C1-6-烷基,-O-C3-7-环烷基,具有3至14个环成员的单环,双环或三环饱和或单或多不饱和碳环,单环,双环或三环饱和或单环-或具有5至15个环成员和1至6个杂原子的多不饱和杂环,R1也是H,条件是当X是CH2时,R1不是H,R3-Z也是NO2,及其药学上可接受的盐,但不包括其中Z为-NH-(C = O)-,-NH-(C = O)-NH-,-NH-(C = O)-O-,-NH-(C的式(I)化合物= O)-CH 2,并且同时R 1是被-COOH,-COOC1-6-烷基,-(CH2)对-COOH,-(CH2)对-COOC1-6-烷基-CONHC1-单取代或多取代的苯基。 6-烷基,-CONHC6-14-芳基,-CONHSO2C1-6-烷基,-CONHSO2C6-4-芳基,1H-四唑-5-基,则R2不是苯基,是单取代的被CN,卤素,C1-4-烷基,C1-4-烷氧基,CF3取代或多取代;如果R3-Z为NO2,则R1-X不是苄基或4-甲氧基苄基,而R2-Y不是苄基或2-甲基吡啶基;以及药物处理过程和制造过程。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号